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SYNTHESIS AND CHARACTERIZATION OF FLUORESCENT NANOJARS

Vageesha Warnajith Liyana Gunawardana, M.S.
Western Michigan University, 2018

Self-assembly is a powerful tool utilized by synthetic chemists to create large, intricate
structures for a variety of applications such as drug delivery, adaptable materials and electronics.
In contrast to stepwise synthesis, this process allows the formation of intricate molecular
architectures starting from synthetically rudimentary building blocks. Nanojars are class of selfassembling, cyclic copper(II) pyrazolate coordination compounds that encapsulate oxoanions with
negative two or three charge. The strong anion binding characteristics of nanojars have potential
towards developing novel tools for detecting biologically and environmentally relevant anions
such as carbonate, sulfate and phosphate.
This work addresses the design and synthesis of several fluorescent pyrazole derivatives as
ligands for nanojars. Three novel fluorescent ligands were prepared and characterized by NMR
and high-resolution mass spectrometry. The subsequent synthesis of nanojars with these ligands
was explored. Preliminary investigation of the photophysical properties of both the ligands and
nanojars using UV/Vis and fluorescence spectroscopies are presented.
In addition, this report examines the amplification of an impurity that was observed in
nanojars. Statistical models were used to fit the experimentally observed distributions of species
in ESI-MS. The broader implications of this discovery to self-assembling molecules in general are
discussed.
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CHAPTER I

INTRODUCTION

1.1. Self-assembly of supramolecular structures
The transformation of a disassociated, random mixture of chemical constituents into welldefined structures is the underlying concept of self-assembly. This process is often mediated
through non-covalent molecular interactions that guide individual components to form intricate
structures, ranging from discrete nano-scale assemblies to large material aggregates (Figure 1.1).
Self-assembling structures are ubiquitous in biological systems. Phospholipids, for example,
spontaneously form a variety of structures in solution such as rods, micelles and bilayers.1,2 This
is in fact the structural basis for cellular membranes, making self-assembly an integral component
of living organisms. Protein self-assembly can lead to amazingly complex structures such as fibers3,
viral capsids4 and catenated rings.5 On the other hand, self-assembly can also lead to undesired
consequences as with the aggregation of Amyloid beta that results in plaques observed in the brains
of patients with Alzheimer’s disease.6
Tools used by synthetic chemists often parallel existing phenomena in biology, whether it
be designed through inspiration or serendipitously discovered. Over the past half century, selfassembly has provided an avenue for chemists to create elaborate structures with applications in
fields such as electronics,7 drug delivery8–10 and self-healing materials.11 In contrast to step-wise
construction of molecules, this process has the advantage of creating complex structures through
simple processes starting from synthetically rudimentary building blocks. Changes in these
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building blocks, in turn, can alter the physiochemical properties, morphology as well as the
topology of the assembled molecules.

Figure 1.1. Examples of biological and artificial self-assembled molecules. A: Structure of Herpes
Simplex viral capsid obtained through cryoelectron microscopy. Reproduced with permission
from Ref. 12. Copyright 1997 John Wiley & Sons, Ltd. B: Simulation of lipid bilayer self-assembly
using molecular dynamics. Reproduced in part from Ref. 13 with permission of the PCCP Owner
Societies. C: Self-assembled artificial muscle-like fibers developed by Feringa and coworkers.
Reprinted with permission from Ref. 14:Springer Nature, Nature Chemistry, Copyright 2017. D:
Heterometallic octahedra metal-organic complex containing Cu2+ and Al3+ ions reported by
Williams et al. Reproduced from Ref. 15 with permission of The Royal Society of Chemistry.
1.2. Self-assembly through coordination chemistry
Self-assembled structures fall into the broader category of supramolecular chemistry,
which encompasses molecules assembled via weak interactions—hydrogen and halogen bonding,
Van der Waal forces, π-stacking, ion-ion interactions, dipole interactions, etc. The lack of
directionality of weak interactions often poses a unique challenge for rational design of
supramolecular complexes. As a result, researchers have often relied on tools from coordination
2

chemistry to address such challenges.16–22 This combines the well-defined coordination geometries
of metals with the versatility of organic ligands as powerful tools for rational design of
macromolecular architectures (Figure 1.2).

Figure 1.2. Schematic showing examples of combining different ligand (red) and metal (blue)
geometries to give 2- and 3-dimentional architectures.
Fujita and coworkers reported an early example of a self-assembled, highly symmetric
structure.23 The assembly is comprised of a pyridine-based, planar tripodal ligand coordinated to
Pd2+ centers in a 2:3 ratio, giving a molecular cage with tetrahedral symmetry (Figure 1.3). Each
metal center had a square planar geometry and each pyridyl ligand was bound cis relative to each
other. The remaining coordination sites were capped with ethylenediamine, forming the discrete
molecular cage instead of an extending framework. When ligand and metal were combined in a
3

ratio of 2:4, the cage was the only product formed and the excess ligand remained in solution. This
result highlights the thermodynamic stability of the cage, disfavoring the formation of other
coordination complexes.
The size of the cage was easily modulated by adjusting the length of each arm of the
tridentate ligand to give particle sizes of 2–5 nm. The central cavity of the of the cage was shown
to accommodate four adamantanecarboxylate molecules. X-ray crystallography showed that the
hydrophobic adamantyl groups occupied the central cavity while the carboxylate groups were
projected to the exterior. Titrations with varying host-guest ratios solely gave cages containing
four encapsulated guests with excess host molecules remaining unchanged. The authors explained
the lack of cages containing 1–3 guests in terms of allosteric binding.

Figure 1.3. Pd2+ metal-organic cage developed by Fujita and coworkers. Reprinted with
permission from Ref. 23:Springer Nature, Nature Chemistry, Copyright 1995.
In 1996, Lehn and coworkers described the synthesis of a self-assembled structure with
five interwoven tris-bipyridyl ligands coordinated to five Fe2+ centers (Figure 1.4A).24 The
resulting structure has the topology of a circular helix. The C5 rotational symmetry of the molecule
4

is confirmed by 1H NMR which showed the terminal methyl groups of the ligands as one singlet
when bound in the complex. The structure inherently has helical chirality arising from the
stereoisomerism of each octahedral metal center. As synthesized, the reaction produced a racemic
mixture containing both the left-handed and right-handed helices. When FeCl2 was used as the
source of Fe2+ the central cavity of the structure was occupied with a chloride ion. The anion was
strongly stabilized by the ten positively charges Fe2+ ions surrounding it.
The Ni2+ complex prepared using the same ligand gave a strikingly different structure
(Figure 1.4B).25 While each metal center still had octahedral geometry, the nickel complex did not
form the pentameric helicate. Instead, they formed a trimeric helical structure with three ligands
intertwined around three metal centers.

B

A

Figure 1.4. Self-assembled metal-organic helicates with a tris-bipyridyl ligand. A: Pentameric
structure with Fe2+ as metal centers. Reprinted with permission from Ref. 24. Copyright 2003 John
Wiley and Sons, Inc. B: Trimeric structure with Ni2+ as metal centers. Reprinted with permission
from Ref. 25. Copyright 2003 John Wiley and Sons, Inc.
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In a later report, Lehn and coworkers presented the importance of counter-anions in the
formation of the self-assembled helicates.26 When FeSO4 was used with the same tris-bipyridyl
ligand as above, the reaction afforded the larger hexameric helicate shown in Figure 1.5. Once
again, 1H NMR confirmed the C6 rotational symmetry of the molecule. The authors attributed the
formation of different structures to the larger size of the SO42– ion compared to Cl–. The same
structure was produced using FeSiF6 and Fe(BF4)2. FeBr2, however, gave a mixture of the
pentameric and hexameric species due to the intermediate size of Br–. On the other hand, using F–
and I– as counterions did not form any helicate, instead giving an unidentified insoluble material.

Figure 1.5. Hexameric helicate reported by Lehn and coworkers using FeSO4 as starting material.
Adapted with permission from Ref. 26. Copyright 1997 American Chemical Society.
The authors also showed that the formation of the tetrameric helicate can be achieved by
altering the linker between bipyridyl groups from CH2CH2 to CH2OCH2 (Figure 1.6). This subtle
change made the ligand slightly longer and more flexible which was sufficient to alter the
parameters of self-assembly. In this case, FeSiF6, Fe(BF4)2 and FeBr2 all gave the same tetrameric
species despite the size of the counter-anion.
6

Figure 1.6. Tetrameric helicate reported by Lehn and coworkers. Adapted with permission from
Ref. 26. Copyright 1997 American Chemical Society.
The work presented by Lehn’s group presents few of the many interdependent variables
that affect self-assembly. Despite the intricacies underlying the mechanisms of self-assembly,
research done by such pioneers in the field have helped us gain better understanding on how to use
this process as a tool for rational design of molecules. As a result, the field of self-assembled
coordination structures has flourished over the past few decades with a plethora of complex
molecules appearing in the literature.27–30 Perhaps the most elegant molecular design for a selfassembling structure was reported by Fujita and coworkers in 2016 (Figure 1.7).31 This structure
consisted of 144 components—48 palladium ions and 96 organic ligands—making it the largest
synthetically constructed molecular cage thus far.32 The cage falls into the morphological category
of Goldberg polyhedra that has a combination of square and triangular faces. The structure was
first theoretically predicted by the authors using planar-graph theory using previously synthesized
smaller polyhedra as their basis.
7

Figure 1.7. Crystal structure of self-assembled polyhedral structure containing 48 palladium
centers joined by 96 bent ligands synthesized by Fujita and coworkers. Image generated with
crystallographic data from Ref. 31:Springer Nature, Nature, Copyright 2016.
1.3. Nanojar self-assembly and anion encapsulation.
While rational design is the ideal for synthetic chemists, serendipitous discoveries are often
the starting point for the development of many supramolecular assemblies.33 Nanojars are class of
Cu2+ based self-assembling coordination compounds that are a result of such discovery (Figure
1.8).34 These assemblies are a conglomeration of three or four metal-organic rings held together
via weak interactions to encapsulate anions of 2– or 3– charge. The nanojar by itself is neutral, and
therefore, will assume the charge of the anion when bound. A typical synthetic procedure involves
simply mixing copper(II) nitrate, pyrazole and a hydroxide base at room temperature in THF.
When a source of anions with large hydration energy is not explicitly added, the formed nanojars
often contain carbonate as the guest. Residual amounts of carbonate from the base or dissolved
carbon dioxide is often sufficient for nanojar synthesis. However, sodium carbonate is added to
reaction mixtures to ensure full conversion.
8

Figure 1.8. X-ray crystal structure of phosphate encapsulating nanojar. Hydrogen atoms are
omitted for clarity. Left: view from the top. Right: view from the side.
The rings are comprised of repeating copper-hydroxy-pyrazolate units with the general
formula [cis-Cu(μ-OH)(μ-pz)]n, n = 6 –14 excluding 11 (Figure 1.9). Each copper ion has a
distorted square planar geometry and is bridged by hydroxo and pyrazolate ligands in cis
conformation. The rings aggregate in different combinations to give nanojar sizes in the range of
26–32 copper centers (Table 1.1). Herein, Cun will refer to the size of the nanojar where n is the
number of copper centers.
Table 1.1. Different ring combinations observed in different sizes of nanojars.

Cu27

6 + 12 + 9

Cu28

6 + 12 + 10

Cu29

7 + 13 + 9
8 + 13 + 8

Cu30

8 + 14 + 8
7 + 14 + 9

Cu31

8 +14 + 9

Cu32

8 + 14 +10

The pyrazolate groups are arranged on the exterior of each ring, giving the nanojar a
hydrophobic shell. The hydroxy groups, on the other hand, point towards the center making the
9

interior highly hydrophilic. These groups help stabilize the anion bound in the center via hydrogen
bonding.35

Figure 1.9. Examples of different ring sizes observed in nanojars. Reproduced with permission
from Ref. 34. Copyright 2004 John Wiley & Sons, Ltd.
The anion binding characteristics of nanojars have parallels in biological systems. For
example, crystal structures of the sulfate encapsulating nanojar shows that it has either eight or
twelve hydrogen bonds stabilizing the anion.35 In fact, this is very similar to the characteristics
within the sulfate binding protein which has seven hydrogen bonds directed to the anion.36 The
addition of Ba(OH)2 to the sulfate containing nanojar does not form the highly insoluble BaSO4
salt, indicating strong binding of the anion within the nanojar.

10

A

B

Figure 1.10. A: Hydrogen bond stabilization of sulfate within the binding site of sulfate binding
protein. Reprinted with permission from Ref. 36 Reprinted with permission from AAAS. B:
Binding of sulfate within the cavity of nanojars. Blue: copper; red: oxygen; yellow: sulfur.
Reproduced from Ref. 35 with permission of The Royal Society of Chemistry.
Nanojars have been shown to be resistant to highly alkaline conditions: stirring a solution
in THF with 10 M solution of NaOH in water for 5 weeks showed no change by ESI-MS.37 On the
other hand, evenly mildly acidic conditions are able to break down nanojars into smaller copper
containing species. This property provides an avenue for the selective assembly and disassembly
of the nanojars as a controllable anion encapsulation technique.
The physiochemical properties of nanojars are highly dependent on the functional groups
on the ligand.38 Groups such as carboxylates, aldehydes and amines on the pyrazole do not form
nanojars, presumably due to having multiple possible coordination sites. Alcohols, however, are
tolerated when it is not bound directly to the pyrazole. The position of substitution on the pyrazole
is important as well. For example, 4-methylpyrazole gives a mixture of Cu27, Cu29, Cu30 and Cu31
nanojars, whereas 3-methylpyrazole predominantly produces the Cu30 species. Sterically bulkier
groups such phenyl rings on the 3-position, as well as disubstituted pyrazoles on the 3- and 5positions do not form nanojars by themselves. Some of these sterically hindered ligands can be
prompted to make nanojars when used in a mixture with unsubstituted pyrazole.
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The solubility of nanojars can also be changed by altering the substituent of the pyrazole
ligand.38 Adding an aliphatic chain makes the nanojar soluble in less polar solvents such as hexanes.
Progressively longer chains make the assembly more lipophilic and can even be made to dissolve
in hexadecane. These hydrophobic nanojars have been shown to be an efficient extraction agent
for carbonate from aqueous to organic media. This is especially impressive as the large hydration
energy of carbonate makes it notoriously difficult to remove from water at high pH.39
1.4. Research objectives
Our long-term goal is to harness the unique properties of nanojars towards developing a
robust technique to detect and quantify anions. Fluorometry and colorimetry are two of the main
avenues for anion detection.40 In comparison to colorimetric techniques, fluorescence often gives
higher sensitivity since only certain molecules fluoresce, thus reducing background interferences.
Thus, in the short term, we aim to develop fluorescent anion encapsulating nanojars.
The objectives of this project are as follows:
a. Design and synthesize fluorescent pyrazole derivatives.
b. Investigate formation of nanojars with the new fluorescent ligands.
c. Study the photophysical properties of both ligands and corresponding nanojars.
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CHAPTER II

EXPERIMENTAL

2.1. General procedures
4-(3-Hydroxypropyl)pyrazole,41,42

4-(2-hydroxyethyl)pyrazole,41,42

1-azidopyrene,43

1-

bromopyrene44 and dichlorobis(triphenylphosphine)palladium(II),45 were synthesized as reported
previously. All other reagents were used as received. THF was dried using sodium/benzophenone
ketyl. Standard Schlenk line technique was used for air and moisture sensitive reactions. Where
specified, solvents were degassed by sonication under house vacuum. Mass spectrometry was
performed on a Waters Synapt G1 HDMS instrument with electrospray ionization (ESI). 1H and
13

C NMR were collected using a Jeol 400 MHz instrument. UV-Vis spectra were collected on a

Shimadzu UV-1650PC instrument and fluorescence studies were conducted on Shimadzu RF5301 and Edinburgh F900 fluorescence spectrometers.
2.2. Synthesis of ligands
2.2.1. Synthesis of 4-(4-pentynyl)pyrazole
2.2.1.1. 4-(3-Bromopropyl)pyrazole

In a 250 mL 3-necked round bottom flask equipped with a jacketed condenser and pressure
equalized addition funnel, 3-(pyrazol-4-yl)propan-1-ol (13.0 g, 103 mmol) was slurried in 1,2dichloroethane (150 mL). Flask was purged with dry N2 and cooled in ice bath. Addition funnel
was charged with phosphorus tribromide (30.0 mL, 85.5 g, 316 mmol) which was added slowly to
the reaction mixture over 40 mins. The resulting mixture was allowed to stir in ice bath for 30
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mins. Condenser equipped with drying tube containing anhydrous calcium chloride and refluxed
for 3h. Cooled to r.t. and let sit overnight. Reaction mixture was cooled in ice bath and quenched
carefully with solid NaHCO3 until pH ≈8 (~75 g). Water (200 mL) was added in small portions.
Dichloromethane (250 mL) added and layers separated. Aqueous layer extracted with
dichloromethane (250 mL × 3). Combined organic layers were washed with water (400 mL × 4)
followed by brine (400 mL). Organic layers were washed again with saturated with saturated
NaHCO3 (400 mL), water (400 mL) and brine (600 mL). Resulting organic layer dried over
anhydrous MgSO4. After filtration, solvent was removed under reduced pressure affording 13.7 g
of a white crystalline solid (71 % yield). 1H NMR (400 MHz, CDCl3): δ 7.44 (s, 2H, 3,5-H-pz),
3.40 (t, 2H, CH2CH2Br, J = 7 Hz), 2.68 (t, 2H, pz-CH2CH2 J = 7 Hz), 2.10 (m, 2H, CH2CH2CH2)
ppm. 13C NMR (101 MHz, CDCl3): δ 132.9, 119.1, 33.7, 33.2, 22.3 ppm. HRMS (ESI-TOF) m/z:
[M + H]+ calcd for C6H10BrN2 189.0027, found 188.9998.
2.2.1.2. 4-(3-Bromopropyl)-1-(tetrahydropyranyl)pyrazole

4-(3-Bromopropyl)pyrazole (10.6 g, 56.1 mmol), acetonitrile (30 mL), 3,4-dihydro-2Hpyran (5.60 mL, 5.16 g, 61.4 mmol) and trifluoracetic acid (0.430 mL, 0.641 g, 5.61 mmol) were
combined in 100 mL round bottom flask and was refluxed under stirring for 7 h. Reaction mixture
was allowed to cool overnight and was quenched with saturated NaHCO3 solution until pH ≈8 was
reached. The resulting mixture was extracted with dichloromethane (30 mL × 2). Combined
organic layers were dried over MgSO4. After filtration, the solvent was removed under reduced
pressure yielding 15.2 g of an orange oil (99 % yield). 1H NMR (400 MHz, CDCl3): δ 7.42 (s, 1H,
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3-H-pz), 7.39 (s, 1H, 5-H-pz), 5.31 (dd, 1H, CH-THP), 4.05 (m, 1H, CH2O-THP), 3.68 (td, 1H,
CH2O-THP), 3.40 (t, 2H, CH2CH2Br, J = 7 Hz), 2.63 (t, 2H, pz-CH2CH2 J = 7 Hz), 1.99-2.19 (m,
5H, CH2CH2CH2, CH2-THP), 1.47-1.87 (m, 3H, CH2-THP) ppm. 13C NMR (101 MHz, CDCl3): δ
139.2, 126.2, 120.2, 87.7, 68.0, 33.5, 33.2, 30.6, 25.0, 22.6, 22.5 ppm. HRMS (ESI-TOF) m/z: [M
+ Na]+ calcd for C11H17BrN2ONa 295.0422, found 295.0414.
2.2.1.3. 4-(4-Pentynyl)-1-(tetrahydropyranyl)pyrazole

In a 500 mL 3-necked round bottom flask under inert atmosphere 4-(3-bromopropyl)-1(tetrahydropyranyl)pyrazole (8.00 g, 29.3 mmol) was dissolved in anhydrous DMF (45 mL).
Reaction flask was cooled in ice bath and sodium acetylide (18% wt. slurry in xylenes, 14.0 mL,
12.3 g, 43.9 mmol) was added slowly over 10 mins. The mixture was allowed to warm to room
temperature. After stirring overnight, NMR showed about ~3% starting material remaining.
Sodium acetylide (18% wt. slurry in xylenes, 9.2 mL, 8.19 g, 30.1 mmol) was added to push
reaction to completion. After stirring overnight, the reaction flask was cooled in ice bath and
carefully quenched with saturated ammonium chloride solution (~100 mL). The resulting mixture
was extracted with dichloromethane (150 mL × 3). Combined organic layers washed with water
(400 mL × 2) and brine (400 mL × 1). Organic layer dried over MgSO4, filtered and solvent
removed under reduced pressure. The resulting brown oil was purified by column chromatography
on silica gel (600 g) using 2:1 hexanes:ethyl acetate as eluent (Rf = 0.38). Impure fractions were
purified again by column chromatography on silica gel (180 g) using 2:1 hexanes:ethyl acetate as
eluent giving a combined yield of 2.81 g of a colorless oil (44%). 1H NMR (400 MHz, CDCl3): δ
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7.40 (s, 1H, 5-H-pz), 7.38 (s, 1H, 3-H-pz), 5.31 (dd, 1H, CH-THP), 4.05 (m, 1H, CH2O-THP),
3.68 (td, 1H, CH2O-THP), 2.58 (t, 2H, pz-CH2CH2, J = 7 Hz), 2.20 (td, 2H, CH2CH2C, J = 7 Hz),
1.99-2.16 (m, 3H, CH2-THP), 1.96 (t, 1H, CCH), 1.76 (m, 2H, CH2CH2CH2), 1.54-1.71 (m, 3H,
CH2-THP) ppm. 13C NMR (101 MHz, CDCl3): δ 139.5, 125.9, 121.1, 87.7, 84.2, 68.7, 67.9, 30.5,
29.5, 25.1, 23.1, 22.7, 17.9 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C13H18N2ONa
241.1317, found 241.1345.
2.2.1.4. 4-(4-Pentynyl)pyrazole

4-(4-Pentynyl)-1-(tetrahydropyranyl)pyrazole (139 mg, 0.637 mmol) and p-toluene
sulfonic acid monohydrate (242 mg, 1.27 mmol) was stirred in methanol (10 mL) for 24 h at r.t.
The reaction was quenched in with saturated NaHCO3 (30 mL). The resulting solution was
extracted with dichloromethane (30 mL × 3). The combined organic layers were dried with Na2SO4
and solvent was removed under reduced pressure. The resulting clear oil was heated under high
vacuum (0.50 mmHg) at 85 °C for 1 h. Product crystallized on the cooler upper part of the flask.
The yellow oil impurity remaining at the bottom of the flask was rinsed off with methanol and
residual methanol was removed under high vacuum. Pure product obtained as a 664 mg of white
needle-like crystals (78%). 1H NMR (400 MHz, CDCl3): δ 7.42 (s, 2H, 3,5-H-pz), 2.63 (t, 2H, C
pz-CH2CH2, J = 7 Hz), 2.21 (td, 2H, CH2CH2C, J = 3, 7 Hz), 1.98 (t, 1H, CCH, J = 3 Hz), 1.79
(m, 2H, CH2CH2CH2) ppm. 13C NMR (101 MHz, CDCl3): δ 132.9, 120.1, 84.2, 29.6, 22.9, 17.8
ppm. HRMS (ESI-TOF) m/z: [M – H]– calcd for C8H9N2 133.0766, found 133.0787.
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2.2.2. Attempted synthesis of 4-(3-butynyl)pyrazole
2.2.2.1. 4-(2-Bromoethyl)pyrazole

In a 100 mL 2-necked round bottom flask equipped with a jacketed condenser, 4-(2hydroxyethyl)pyrazole (0.96 g, 8.56 mmol) was slurried in 1,2-dichloroethane (15 mL). Flask was
purged with inert atmosphere and cooled in ice bath. Phosphorus tribromide (4.2 mL, 12.0 g, 44.2
mmol) was added slowly to the reaction mixture via syringe over 10 mins. The resulting mixture
was allowed to stir in ice bath for 10 mins. Condenser equipped with drying tube containing
anhydrous calcium chloride and refluxed for 3 h. Cooled to r.t. and stirred for a further 4 h.
Reaction mixture was cooled in ice bath and quenched carefully with saturated NaHCO3 solution
until pH ≈8 (~75 g). Dichloromethane (100 mL) added and layers separated. Aqueous layer
extracted with dichloromethane (100 mL × 4). Combined organic layers dried over anhydrous
Na2SO4. After filtration, solvent was removed under reduced pressure affording 1.28 g of a white
solid (85 %yield). The crude product was used in the next step without further purification. 1H
NMR (400 MHz, CDCl3): δ 7.50 (s, 2H, 3,5-H-pz), 3.50 (t, 2H, pz-CH2CH2Br), 3.08 (t, 2H, pzCH2CH2Br) ppm.
2.2.2.2. 4-(2-Bromoethyl)-1-(tetrahydropyranyl)pyrazole

4-(2-bromoethyl)pyrazole (1.27 mg, 7.26 mmol), acetonitrile (30 mL), 3,4-Dihydro-2Hpyran (0.728 mL, 0.671 g, 7.98 mmol) and trifluoracetic acid (6.0 µL, 8.94 mg, 0.784 mmol) were
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combined in 100 mL round bottom flask and was refluxed under stirring for 3h. Reaction vessel
allowed to cool overnight. Solvent was removed by rotary evaporation and the residue was redissolved in dichloromethane (20 mL). The resulting mixture was washed with saturated NaHCO3
solution (25 mL × 2). Organic layer was dried over MgSO4. After filtration, the solvent was
removed under reduced pressure yielding 1.68 g of an orange oil (89 % yield). The crude product
was used in the next step without further purification. 1H NMR (400 MHz, CDCl3): δ 7.51 (s, 1H,
3-H-pz), 7.45 (s, 1H, 5-H-pz), 5.34 (dd, 1H, CH-THP), 4.05 (m, 1H, CH2O-THP), 3.69 (td, 1H,
CH2O-THP), 3.47 (t, 2H, pz-CH2CH2Br, J = 7 Hz), 3.03 (t, 2H, pz-CH2CH2Br J = 7 Hz), 1.992.12 (m, 3H, CH2CH2CH2, CH2-THP), 1.52-1.73 (m, 3H, CH2-THP) ppm.
2.2.2.3. Reaction of 4-(2-bromoethyl)-1-(tetrahydropyranyl)pyrazole with sodium acetylide

In a 100 mL 2-necked flask, 4-(2-bromoethyl)-1-(tetrahydropyranyl)pyrazole (1.68 g, 6.48
mmol) was dissolved in 15 mL of anhydrous DMF and flask was purged with N2. Reaction flask
was cooled in ice bath and sodium acetylide (18% wt. slurry in xylenes, 5.0 mL, 4.5 g, 17 mmol)
was added slowly over 5 mins. The reaction vessel was allowed to warm to r.t. overnight. Reaction
cooled in ice bath and quenched with water (20 mL). Once bubbling had subsided, the resulting
mixture was extracted with dichloromethane (50 mL × 3). Combined organic layers were washed
with water (100 mL × 3) and brine (100 mL). Organic layer dried over Na2SO4 and solvent
removed under reduced pressure. NMR did not show evidence for the formation of the desired
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alkyne product. The major product was the terminal alkene formed through the
dehydrobromination of the substrate.
2.2.3. Synthesis of 4-(3-azidopropyl)pyrazole
2.2.3.1. 4-(3-Azidopropyl)-1-(tetrahydropyranyl)pyrazole

4-(3-Bromopropyl)pyrazole (1.50 g, 5.49 mmol) and sodium azide (0.55 g, 8.31 mmol)
were heated in DMF (16 mL) at 80 °C, overnight. Completion of reaction was confirmed by NMR
and mixture was diluted with water (50 mL). The resulting mixture was extracted with ethyl acetate
(100 mL × 3). Combined organic layers washed with water (100 mL) and brine (100 mL). The
resulting organic layer was dried over MgSO4 and solvent removed under reduced pressure giving
1.20 g of an orange oil (93 %). The crude product was not purified. 1H NMR (400 MHz, CDCl3):
δ 7.40 (s, 1H, 3-H-pz), 7.38 (s, 1H, 5-H-pz), 5.31 (dd, 1H, CH-THP), 4.05 (m, 1H, CH2O-THP),
3.68 (td, 1H, CH2O-THP), 3.28 (t, 2H, CH2CH2N3, J = 7 Hz), 2.55 (t, 2H, pz-CH2CH2N3, J = 7
Hz), 1.99-2.19 (m, 3H, CH2-THP), 1.84 (m, 2H, CH2CH2CH2), 1.47-1.87 (m, 3H, CH2-THP) ppm.
2.2.4. Synthesis of 4-(3-(pyrazol-4-yl)propyl)-1-(pyrenyl)-1,2,3-triazole
2.2.4.1. 4-(3-(Pyrazol-4-yl)propyl)-1-(pyrenyl)-1,2,3-triazole (pz-tri-py)
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In a 100 mL 2-necked round bottom flask 4-(4-pentynyl)-1-(tetrahydropyranyl)-pyrazole
(497 mg, 2.28 mmol) and 1-azidopyrene (554 mg, 2.28 mmol) were dissolved in THF (25 mL).
CuSO4·5H2O (853 mg, 3.42 mmol) dissolved in water (15 mL) was transferred to the reaction
vessel. Flask was purged with dry N2. Freshly prepared solution of sodium ascorbate by combining
ascorbic acid (2.41 g , 13.7 mmol) and sodium bicarbonate (1.18 g, 14.0 mmol) in water (15 mL)
was added to the reaction mixture. THF (10 mL) was used to rinse walls of flask and allowed to
stir for 4 days. The bright red solution was quenched with NH4OH (30% wt, 50 mL). The resulting
mixture was extracted with chloroform (80 mL × 4). Combined organic layers were washed with
water (100 mL × 2) ad brine (200 mL × 1). The organic layer was dried over MgSO4, filtered and
concentrated under reduced pressure to give 823 mg of a red solid (crude yield: 78.3%).
The residue from the previous step was dissolved in ethanol (50 mL) and concentrated
sulfuric acid was added (0.60 mL). After stirring overnight, the reaction was quenched with
saturated sodium bicarbonate solution until pH ~8. The resulting solution was extracted with
chloroform (100 mL × 3). Combined organic layers washed with water (200 mL × 2) and brine
(200 mL × 2). Dried over Na2SO4, filtered and concentrated under reduced pressure to give a red
solid. This was then dissolved in a minimal amount of chloroform and excess diethyl ether was
added to form a brown precipitate that was filtered and rinsed generously with diethyl ether.
Residual solvent was removed under vacuum to afford 400 mg of a brown powder (47% over 2
steps). 1H NMR (400 MHz, DMSO-d6): δ 8.57 (s, 1H, triazole-H), 8.49-8.18 (m, 8H, pyrene-H),
7.80 (d, 1H, pyrene-H, J = 9 Hz), 7.51 (br, 2H, 3,5-H-pz), 2.85 (t, 2H, C pz-CH2CH2, J = 7 Hz),
2.60 (t, 2H, CH2CH2C, J = 7 Hz), 2.02 (m, 2H, CH2CH2CH2) ppm. 13C NMR (101 MHz, DMSOd6): δ 147.8, 132.1, 131.3, 131.2, 130.7, 130.1, 129.3, 127.7, 127.1, 126.7, 125.9, 125.7, 125.7,
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124.6, 124.4, 123.9, 121.7, 119.8, 31.1, 25.2, 23.8 ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd
for C24H19N5Na 400.1538, found 400.1533.
2.2.5. Synthesis of 4-(pyren-1-yl)pyrazole
2.2.5.1. 1-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1Hpyrazole

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (1.50 g, 7.73 mmol),
acetonitrile (20 mL), 3,4-dihydro-2H-pyran (776 µL, 715 mg, 8.51 mmol) and trifluoracetic acid
(50.0 µL, 74.5 mg, 0.653 mmol) were combined in 50 mL round bottom flask and was refluxed
under stirring overnight. Reaction vessel allowed to cool overnight and was quenched with
saturated NaHCO3 solution until pH ≈8 was reached. The resulting mixture was extracted with
dichloromethane (30 mL x 3). Combined organic layers were dried over Na 2SO4. After filtration,
the solvent was removed under reduced pressure yielding 1.90 g of an orange oil that solidified
upon standing (88.5 % yield). 1H NMR (400 MHz, CDCl3): δ 7.91 (s, 1H, 5-H-pz), 7.80 (s, 1H, 3H-pz), 5.38 (dd, 1H, CH-THP, J = 9 Hz, 3 Hz), 4.02 (d, 1H, CH2O-THP, J = 10 Hz), 3.67 (td, 1H,
CH2O-THP, J = 11 Hz, 3 Hz ), 1.92-2.20 (m, 3H, CH2-THP), 1.52-1.77 (m, 3H, CH2-THP), 1.28
(s, 12H, CH3) ppm.
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C NMR 145.5, 134.8, 87.4, 67.8, 30.6, 25.0, 24.9, 24.8, 22.4 (101 MHz,

CDCl3): δ ppm. HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C14H23BN2O3Na 300.1736, found
300.1754.
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2.2.5.2. 4-(Pyren-1-yl)pyrazole (py-pz).

Under inert atmosphere, 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
(1.00 g, 3.60 mmol) and 1-bromopyrene were dissolved in a degassed 5:1 mixture of dioxane and
water (60 mL). Pd(PPh3)4 (413 mg, 0.360 mmol) and K2CO3 (1.50 g, 10.8 mmol) were added, and
the reaction mixture was refluxed for 5 h. After cooling to r.t., the mixture was diluted with water
(100 mL) and the resulting solution was extracted with ethyl acetate (100 mL × 2). Combined
organic layers were washed with brine (400 mL × 2) and dried over Na2SO4. Solvent removed
under reduced pressure to afford a dark brown oil. This residue was dissolved in ethanol (100 mL)
followed by the addition of concentrated H2SO4 (5.5 mL). After stirring overnight, the reaction
was quenched with saturated NaHCO3 solution until pH ≈8 was reached. The resulting solution
was extracted with chloroform (100 mL × 2). Combined organic layers were washed with water
(400 mL × 2) and brine (400 mL × 1), and dried over Na2SO4. Solvent was removed under reduced
pressure and the resulting brown solid was purified by flash chromatography on silica gel (200 g)
using 2:1 ethyl acetate:hexanes as eluent (Rf = 0.36) affording 550 mg of the pure product as a
yellow solid (57 % yield). 1H NMR (400 MHz, DMSO-d6): δ 8.44 (d, 1H), 8.26-8.31 (m, 4H),
8.16-8.20 (m, 3H), 7.90-8.10 (m, 3H) ppm. 13C NMR (101 MHz, DMSO-d6): δ 139.7, 131.6, 131,1,
130.0, 129.4, 128.9, 128.2, 128.1, 128.0, 128.0, 127.5, 126.9, 125.7, 125.3, 124.9, 124.7, 120.2
ppm. HRMS (ESI-TOF) m/z: [M - H]- calcd for C19H11N2 267.0922, found 267.0952.
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2.2.6. Synthesis of 4-(5-(pyren-1-yl)pent-4-ynyl)pyrazole
2.2.6.1. 4-(5-(Pyren-1-yl)pent-4-ynyl)pyrazole (pz-alk-py)

In 50 mL Schlenk flask, 4-(4-pentynyl)-1-(tetrahydropyranyl)-pyrazole (703 mg, 3.21
mmol), 1-bromopyrene (901 mg, 3.21 mmol) and Pd(PPh3)2Cl2 (225 mg, 0.321 mmol) were
dissolved in degassed triethylamine (20 mL) under inert atmosphere. CuI (6.1 mg, 0.032 mmol)
was added and the reaction was stirred at 65 °C overnight. The solution was allowed to cool to r.t.
and was filtered with ethyl acetate as the rising solvent. Solvent was removed under reduced
pressure. The resulting residue was dissolved in methanol (25 mL) followed by the addition of ptoluene sulfonic acid monohydrate (1.23 g, 6.47 mmol). The reaction was stirred for two days and
quenched with saturated NaHCO3 solution (100 mL). The resulting mixture was extracted with
chloroform (60 mL × 3). Combined organic layers were dried over Na2SO4 and solvent removed
under reduced pressure giving 1.12 g of crude. This residue was purified by flash chromatography
on silica gel (150 g) with 3:2 ethyl acetate:hexanes as eluent giving 0.355 g of an orange oil. This
was further purified by flash chromatography on silica gel (50 g) with 49:1 chloroform:methanol
as eluent giving 0.24 g of orange oil (22% yield over two steps). 1H NMR (400 MHz, CDCl3): δ
8.56 (d, 1H), 7.99-8.21 (m, 8H), 7.52 (s, 2H), 2.83 (t, 2H, J = 8 Hz), 2.69 (t, 2H, 8 Hz), 2.04 (m,

23

2H, 7 Hz) ppm. 13C NMR (101 MHz, CDCl3): δ 133.0, 131.9, 131.4, 131.2, 130.8, 129.7, 128.2,
127.9, 127.3, 126.2, 125.7, 125.5, 124.6, 124.5, 120.3, 118.8, 95.7, 80.3, 30.2, 23.4, 19.4 ppm.
2.2.7. Representative synthesis of homoleptic nanojars
Ligand (1 mmol), Cu(NO3)2•2.5H2O (1 mmol), NaOH (2.13 mmol) and Na2CO3•H2O (1
mmol) were stirred in THF (10 mL) for 3 days. The resulting deep blue solution was filtered, and
solvent was removed under reduced pressure to give nanojar mixture.
2.2.7.1. Na2[CO3⊂{Cu(OH)(HCC(CH2)3)pz)}n] (n = 27, 29, 31)
Reaction using 4-(4-pentynyl)pyrazole (63.0 mg, 0.470 mmol) gave 0.11 g of blue solid
(100% yield based on Cu29 nanojar). ESI-TOF MS: [{Cu(OH)(HCC(CH2)3)pz)}27]2– (m/z 2929),
[{Cu(OH)(HCC(CH2)3)pz)}29]2– (m/z 3144), [{Cu(OH)(HCC(CH2)3)pz)}31]2– (m/z 3359).
2.2.7.2. Na2[CO3⊂{Cu(OH)(py-pz)}n] (n = 27, 29)
Reaction using 4-(pyren-1-yl)pyrazole (49.9 mg, 0.186 mmol) gave 40.6 mg of dark green
solid (62% yield based on Cu27 nanojar). [{Cu(OH)(py-pz)}27]2– (m/z 4726), [{Cu(OH)(pypz)}29]2– (m/z 5074).
2.2.8. Representative synthesis of heteroleptic nanojars
Ligands combined in desired ratios (total ligand 1 mmol). Cu(NO3)2•2.5H2O (1 mmol),
NaOH (2.13 mmol) and Na2CO3•H2O (1 mmol) were added and stirred in THF (10 mL) for 3 days.
The resulting deep blue solution was filtered, and solvent was removed under reduced pressure to
give nanojar mixture.
2.2.9. Nanojar preparation with varying ratios of pyrazole and 4-methylpyrazole
Reactions were carried out in 2-dram scintillation vials with magnetic stirbars. Stock
solutions of pyrazole (1.81 × 10–1 M), 4-methylpyrazole (3.36 × 10–2 M), Cu(NO3)2•2.5H2O (3.48
× 10–1 M) and Bu4NOH (1.05 M) were prepared in THF. Pyrazole (pz) and 4-methylpyrazole (424

Mepz) solutions were combined in ratios of 100:0, 99:1, 98:2, 97:3, 96:4, 95:5, 94:6, 93:7, 92:8,
91:9 and 90:10, respectively (Table 2.1 summarizes actual mole fraction of Mepz, f, in each), for
a total of 70.6 µmol of ligand. Under rapid stirring, Cu(NO3)2•2.5H2O solution (200 µL, 69.6 µmol,
1.0 eq.) was added, followed by Bu4NOH solution (138 µL, 145 µmol, 2.05 eq.) causing the
solution to turn a deep blue color. After stirring for 5 mins, this solution was poured into H2O (~10
mL). The resulting blue precipitate was filtered out, rinsed with water and dried in air. Mass
spectrometry samples were prepared by dissolving the complete amount obtained from the
reactions in mass spectrometry grade acetonitrile (25.0 mL, 97 mM assuming quantitative yield).
The electrospray capillary voltage was set to 2.5 kV with desolvation temperature of 85 °C.
Sampling and extraction cones were set at 40 V and 1.0 V, respectively. The source temperature
was 80 °C with nebulizing gas supplied at 250 L/h. Samples were infused at 10–25 µL/min.
Table 2.1. Actual mole fractions of 4-methylpyrazole, f, in each reaction mixture.

[pz:Mepz]

f

[100:0]

0

[99:1]

0.0096

[98:2]

0.0192

[97:3]

0.0289

[96:4]

0.0385

[95:5]

0.0482

[94:6]

0.0577

[93:7]

0.0674

[92:8]

0.0771

[91:9]

0.0867

[90:10]

0.0964
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2.2.10. Fluorescence quantum yield measurements
All quantum yield measurements were carried out using 9,10-diphenylanthracene standard
as described previously.46 The solvent for the standard was EtOH and the solvent for the analytes
was acetonitrile.
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CHAPTER III

SYNTHESIS OF FLUORESCENT NANOJARS

3.1. Synthesis and characterization of pyrazolyl ligands
3.1.1. Synthesis of terminal alkyne functionalized pyrazole
Alkynes are versatile functional groups that allow a myriad of transformations from classic
Diels-Alder cycloadditions47 to multicomponent tandem reactions.48 We were interested in
developing alkyne functionalized pyrazoles as an avenue to constructing nanojars that have
potential to be functionalized both pre- and post-synthetically. This in turn would allow us to
broaden the applicability of nanojars towards areas such as drug delivery, anion recognition and
adaptable materials.
Previous investigations have shown that steric contributions from bulky substituents at the
3-position on pyrazolyl ligands can hinder the formation of nanojars.38 Thus, we established that
functionalization at the 4-position would in turn minimize such complications. Long alkyl chains
were tolerated even in the 3-position, conceivably due to their flexibility, allowing them to assume
conformations that reduce steric interactions. We identified 4-(4-pentynyl)pyrazole as a suitable
starting point for our studies as it would provide radial accessibility on nanojars as well as
sufficient conformational freedom to reduce steric strain. This compound has been previously
prepared from 4-(3-hydroxypropyl)pyrazole by first converting the hydroxyl group to the primary
bromide using thionyl bromide and subsequently performing a nucleophilic substitution reaction
with sodium acetylide to give the alkyne (Scheme 3.1).49 It must be noted that the sodium acetylide
was prepared by reacting sodium metal with acetylene gas in liquid ammonia.
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Scheme 3.1. Previously published procedure for the synthesis of 4-(4-pentynyl)pyrazole from 4(3-hydroxypropyl)pyrazole.49
4-(4-Pentynyl)pyrazole was synthesized with modifications to the original procedure
(Scheme 3.2). 4-(3-Hydroxypropyl)pyrazole was synthesized from 3,4-dihydropyran by first
carrying out an addition reaction with triethyl orthoformate, with boron trifluoride diethyl etherate
as catalyst. Subsequent cyclization with hydrazine dihydrochloride and aromatization afforded the
crystalline product in a yield of 66% over two steps. The alcohol was then converted to 4-(3bromopropyl)pyrazole using phosphorus tribromide.

Scheme 3.2. Modified synthesis of 4-(4-pentynyl)pyrazole from 3,4-dihydropyran.
In order to avoid using sodium metal and acetylene gas, we used sodium acetylide that is
commercially available as a slurry in xylenes and mineral oil. The pyrazole amine was first
protected with a tetrahydropyranyl (THP) group prevent possible polymerization products by
heteromolecular substitution reactions of the pyrazolate. In turn, the substitution reaction with
sodium acetylide to the THP protected 4-(4-pentynyl)pyrazole proceeded with DMF as solvent.
NMR showed that the crude product contained about 8% of the allyl pyrazole formed through the
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dehydrobromination of the substrate (Figure 3.1). The signal appearing at 5.94 ppm with the
complex splitting pattern corresponds to the proton germinal to the substituted position on the
alkene. The two terminal proton signals appear as a pair of doublets at 5.33 ppm and 5.30 ppm.

*

*
* **
**
*

*

*
ppm

Figure 3.1. 1H NMR of crude 4-(4-pentynyl)pyrazole containing about 8% of allyl pyrazole
impurity. Signals for pyrazolyl and aliphatic substituent protons indicated with asterisks. Inset
shows zoomed in view of the alkene chemical shift region.
Initially, this crude product was used directly in the removal of the THP group with
concentrated hydrochloric acid and purified with vacuum distillation to give 4-(4pentynyl)pyrazole with 44% yield over two steps. Due their similar structures, the impurity was
only decreased to about 2.5% through this method. We found that better purity can be achieved by
first purifying the THP-protected 4-(4-pentynyl)pyrazole by flash chromatography followed by
deprotection using p-toluenesulfonic acid to give the product containing less than 1% of the allyl

29

pyrazole impurity. This method, however, gave a moderately lower yield of 34% over two steps
and an overall synthetic yield of 16% for 4-(4-pentynyl)pyrazole over six steps.
In extension to the synthesis above, we attempted to obtain 4-(3-butynyl)pyrazole using a
similar route (Scheme 3.3). The preparation of 4-(2-hydroxyethyl)pyrazole was reproduced as
reported starting from 2,3-dihydrofuran with a yield of 71% over two steps.41 As before, the
alcohol was converted to the terminal bromide using phosphorus tribromide and the pyrazole
amine was protected using a THP group. With insight from previous experiments, we expected the
reaction of the bromide with sodium acetylide to give the terminal alkyne with some
dehydrobromination alkene impurity. To our surprise, the reaction exclusively afforded the vinyl
pyrazole product. We believe that the increased conjugation by the formation of the alkene results
in a significantly more stable product.

Scheme 3.3. Attempted synthesis of 4-(3-butynyl)pyrazole 2,3-dihydrofuran.
3.1.2. Synthesis of fluorescent pyrazole ligands
Pyrene is a widely used fluorophore in luminescent sensors due to its well characterized
photophysical properties, high fluorescence quantum yield and long lifetimes of its excited
state.50,51 We envisioned functionalizing pyrazoles with a pyrene label as ligands to synthesize
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fluorescent nanojars. A key challenge of developing luminescent nanojars is that paramagnetic
metal ions such as Cu2+ are known to effectively quench fluorescence by promoting intersystem
crossing of the singlet excited state to the triplet state.52 NMR studies done by our group on a
similarly paramagnetic Ni2+ complex with 4-octylpyrazolate complex showed that the chemical
shifts of the protons on the carbon benzylic to the pyrazole were susceptible to the paramagnetism
of the metal centers.53 Chemical shifts of protons on subsequent carbon atoms were not affected
indicating that these positions were sufficiently isolated from the paramagnetic effects of Ni2+.
Thus, we expected that the proximity and linking functional group between the pyrene and
pyrazole will affect the photophysical properties of their corresponding nanojars. As such, we
wished to explore a range of pyrene functionalized pyrazoles with different linkers.
The simplest fluorescent ligand was synthesized by directly attaching pyrene to the 4position of the pyrazole (Scheme 3.4). The commercially available 4-pyrazoleboronic acid pinacol
ester was protected with THP, followed by a Suzuki-Miyaura coupling with 1-bromopyrene. The
resulting crude product was used directly in the deprotection and was purified by flash
chromatography to give the 4-(pyren-1-yl)pyrazole (py-pz) with 50% overall yield.

Scheme 3.4. Synthesis of py-pz.

31

In previous reports, copper catalyzed azide-alkyne cycloaddition “click” reaction has
shown to be a convenient method to install pyrene based fluorophores on larger molecular
structures containing alkyne functionality.43,54–58 We proceeded to couple the previously
synthesized THP-protected 4-(4-pentynyl)pyrazole with 1-azidopyrene using click chemistry
(Scheme 3.5). The Cu1+ catalyst was formed in situ by the reduction of Cu2+ using sodium
ascorbate. The resulting crude product was deprotected using concentrated sulfuric acid in ethanol.
The product was purified by dissolving in minimal amount of chloroform and precipitating with
hexanes. Filtration gave the pure 4-(3-(Pyrazol-4-yl)propyl)-1-(pyrenyl)-1,2,3-triazole (pz-tri-py)
with 47% yield over two steps.

Scheme 3.5. Click reaction of THP protected 4-(4-pentynyl)pyrazole and 1-azidopyrene, followed
by deprotection.
We recognized that the terminal alkyne can be directly coupled to the pyrene using a
Sonogashira reaction. The coupling reaction was carried out using the THP-protected 4-(4pentynyl)pyrazole and the corresponding coupling partner, 1-bromopyrene.44 Using Pd(PPh3)4
produced the pyrene coupled product along with about 16% of Glaser-type homocoupled di-alkyne.
Replacing the catalyst with Pd(PPh3)2Cl2 reduced the side product to about 4%. Direct deprotection
and purification by flash chromatography afforded 4-(5-(Pyren-1-yl)pent-4-ynyl)pyrazole (pz-alkpy) in 22% yield over two steps.
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Figure 3.2. Sonogashira coupling of THP-protected 4-(4-pentynyl)pyrazole and 1-bromopyrene
and subsequent deprotection.
3.2. Alkyne functionalized carbonate encapsulating nanojar
Several methods for the synthesis of nanojars have been developed.38,59 The choice of base
determines the counterion on the nanojar and can be exchanged by cation metathesis. The
counterion has been shown to be important in certain properties of nanojars such as solubility and
solid state structure.38 In our case, we were concerned by the effect of the counter cation on the
ionization efficiency in ESI-MS. Tetrabutylammonium has been shown to significantly reduce
ionization of nanojars containing long hydrophobic chains, potentially due to Van der Waal
interactions between these functional groups and counterion.35,38 Thus, all nanojars in this study
that contain large functional groups were prepared using sodium as counterion.
The carbonate-encapsulating nanojar synthesis with 4-(4-pentylnyl)pyrazole gave a
mixture of different sized nanojars with general formula Na2[CO3⊂{Cu(OH)(4-Rpz)}n] where n
= 27, 30, 31 and R = (CH2)3CCH (Figure 3.3). Cu27 was found in much higher abundance than
Cu29 and Cu31, conceivably due to being the most stable size for carbonate containing nanojar,
demonstrated previously for unsubstituted pyrazole nanojars.37
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Figure 3.3. ESI-MS of nanojar mixture using 4-(4-pentylnyl)pyrazole with general formula of
Na2[CO3⊂{Cu(OH)(4-Rpz)}n] where n = 27, 30, 31. M/z values reflect half the mass of [CO3⊂
{Cu(OH)(4-Rpz)}n]2+ ion.
3.3. Synthesis of fluorescent nanojars
Structures of synthesized fluorescent pyrazoles are summarized in Figure 3.4. The
synthesis of homoleptic and heteroleptic nanojars with these ligands was explored.

Figure 3.4. Structures of fluorescent pyrazoles synthesized in this study.
3.4.1. Pz-tri-py as ligand
Nanojars were not observed in ESI-MS using pz-tri-py as the ligand. The reaction mixture
formed a brown insoluble solid. The triazole functionality is also a possible coordination site for
copper which would potentially allow the formation of coordination polymers. This is consistent
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with previous studies which showed that nanojars do not form with pyrazole ligands containing
additional coordinating functional groups.38
Our group had previously shown that pyrazole ligands that do not usually form nanojars
on their own may form mixed nanojars when synthesized in conjunction with equimolar amount
of unsubstituted pyrazole.38 In the case of pz-tri-py, no nanojars were observed in [pz:pz-tri-py]
ratios of [50:50] and [85:15]. Unidentified copper containing species with m/z < 1000 were
observed in ESI-MS for both these cases. Distribution of nanojars, however, were formed with
[95:5] [pz:pz-tri-py] indicating that pz-tri-py is tolerated on nanojars in small numbers. Cu27 and
Cu31 were the only sizes formed in this case, and each had up to four substitutions of pz-tri-pz.

Figure 3.5. ESI-MS showing distribution of nanojars obtained with [95:5] [pz:pz-tri-py] ligand
mixture.
3.4.2. Py-pz as ligand
Cu27 and Cu29 nanojars were observed in ESI-MS using py-pz. The signal intensity,
however, was very low indicating poor ionization efficiency, conceivably due to the size and
hydrophobicity of the assemblies.
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Figure 3.6. ESI-MS of nanojar mixture obtained using py-pz as ligand.
1

H NMR of the nanojar mixture showed peaks in the 20 – 40 ppm range that are consistent

with previous observations for nanojars.37,60 Paramagnetic effects of Cu2+ shifts the pyrazolate
proton signals significantly downfield. Paramagnetically induced chemical shits are temperature
dependent. Therefore, variable temperature 1H NMR was used in an attempt to deconvolute
overlapping peaks (Figure 3.7).
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Figure 3.7. Variable temperature 1H NMR spectrum of py-pz nanojar showing pyrazolate proton
region.
At 25 °C, the spectrum showed four broad distinguishable peaks at 30.3, 27.1, 22.4 and
21.2 ppm. As temperature increased, these peaks became sharper as the paramagnetic effects of
copper decrease. The chemical shift of the peak at 30.3 ppm remains largely unchanged but
disappears as temperature increased. The peak at 27.1 ppm shifted slightly up field to 26.6 ppm at
140 °C and became significantly sharper. Higher temperatures showed that peaks at 22.4 and 21.2
in fact had overlapping peaks hidden underneath which had sufficient changes in chemical shift to
be identified. A new peak at 34.0 ppm appeared at 50 °C. This signal had the most significant
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change in chemical shift with change in temperature. Furthermore, the peak had the highest
amplitude at 80 °C and mostly disappeared at 140 °C.
Nanojar synthesized with 1:1 mixture of unsubstituted pyrazole and 4-(pyren-1-yl)pyrazole
formed a distribution of nanojars consisting primarily of Cu27 species. Ratios of [pz:py-pz] ranged
from [24:3] to [8:19] with the [16:11] species having the highest abundance. The ionization
efficiency of these assemblies were drastically better than those containing only 4-(pyren-1yl)pyrazole as ligand.

Figure 3.8. ESI-MS distribution of nanojars synthesized with a 1:1 mixture of unsubstituted
pyrazole and py-pz.
3.4.3. Pz-alk-py as ligand
While there were some peaks with low intensity in the expected mass region for the
nanojars, unequivocal formation of nanojars with pz-alk-py was not determined with ESI-MS. The
change in the color of the reaction from pale blue to dark green did suggest that nanojars may have
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been formed. It is possible that these nanojars are not ionizable with electrospray ionization
because they are large and hydrophobic.
On the other hand, binary ligand combination of pz-alk-py and unsubstituted pyrazole gave
a distribution of nanojars.

The ionization efficiency of these assemblies in ESI-MS were

significantly less than that of nanojars containing only unsubstituted pyrazole. However, the mass
spectrum gave sufficient signal to noise ratio to distinguish and identify the different species.
Distributions of Cu27 were primary components. Smaller amounts of the Cu29 and Cu31 nanojars
were observed.

Figure 3.9. ESI-MS showing distribution of nanojars synthesized with 1:1 mixture of pyrazole
and pz-alk-py. Numbers in square brackets indicate ratios of ligands in the Cu27 species observed.
Minor Cu29 and Cu31 species are labeled with stars (red: Cu29; blue: Cu31).
3.5. Post-synthetic modification of alkyne-functionalized nanojars
The term “click chemistry” was coined by Barry Sharpless in 2002 to describe reactions
that have high thermodynamic driving forces, good yields and simple reaction conditions.61 Since
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then, this term has mainly come to signify the Huisgen alkyne-azide cycloaddition reaction.62
Initially, reaction conditions involved heating the azide and alkyne reagents giving a mixture of
1,4- and 1,5-regioisomers of cycloaddition triazole product (Figure 3.10A). The breakthrough in
the reaction was achieved by Sharpless and coworkers developing a Cu(I) catalyzed click reaction
that proceeded under milder conditions.63 Furthermore, the resulting product contained exclusively
the 1,5-regioisomer (Figure 3.10B).

A

B

Figure 3.10. A: Huisgen alkyne-azide cycloaddition reaction. B: Cu(I) catalyzed alkyne-azide
cycloaddition reaction.
Click chemistry is used as an easy method to functionalize molecules ranging from small
carbohydrates to macromolecules such as proteins.64–66 We were interested in utilizing click
chemistry to functionalize nanojars containing terminal alkynes post-synthetically. Specifically,
we proposed to attach a pyrene fluorophore (Figure 3.11).
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Figure 3.11. Schematic for the post-synthetic functionalization of alkyne containing nanojars with
1-azidopyrene via click chemistry.
In most click reactions, the Cu(I) is generated in situ by reducing Cu2+ with an excess of
sodium ascorbate.67 This prevents Glaser-type oxidative homocoupling products of alkynes. We
were concerned that the reducing agent may interfere with nanojars. Thus, we proceeded to use
CuI as catalyst. Furthermore, since we had previously observed that the coupled product, pz-tripy, is only tolerated on nanojars in small amounts, nanojars prepared with 90:10 ratio of pyrazole
and 4-(4-pentylnyl)pyrazole were used for this study.
Coupling reactions were conducted in degassed solvent and stirred for 5 days under N2. A
small aliquot of the reaction was taken for analysis by ESI-MS. Using THF as a solvent, nanojars
containing up to three pyrene groups were observed. A significant number of nanojars containing
unreacted alkyne moieties remained. We suspected that insolubility of CuI in THF may have been
a cause. To test this hypothesis, we carried out the reaction in ACN which is able to dissolve the
catalyst. This, however, produced a blue precipitate that contained nanojars with higher number of
pz-tri-py. On the other hand, the mother liquor contained uncoupled nanojars and those containing
only one pz-tri-py ligands. The increasing hydrophobicity of the assembly with increasing number
of coupled ligands makes them progressively less soluble in ACN.
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A
B
C
D

Figure 3.12. ESI-MS for coupling of nanojars with 1-azidopyrene. A: Initial nanojar distribution.
B: THF as solvent. C: ACN as solvent. D: THF:ACN 1:1 as solvent. Ratios of each ligand in a
given species is given in square brackets.
In an attempt to prevent the precipitation of the larger assemblies as well as dissolve the
catalyst, we tried the reaction in a 1:1 mixture of THF and ACN. Most of alkyne ligands have
reacted in this case. However, the abundances of the nanojars containing pyrene coupled ligands
were lower than expected. It is unclear whether this is due to decreasing ionization efficiency of
the complexes containing pz-tri-py or to other reactions that are consuming the alkyne ligands.
These experiments clearly show that nanojars can be functionalized post-synthetically.
Further experimentation must be conducted in order to optimize parameters to obtain a single
species of the pyrene coupled nanojars.
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3.6. Preliminary photophysical studies
3.6.1. UV/Vis spectroscopy
Preliminary UV/Vis studies were carried out on fluorescent ligands and select nanojars in
acetonitrile. The concentrations of nanojars were estimated using the mass of the most abundant
nanojar species. Pz-alk-py and pz-tri-py had distinct vibrionic bands characteristic of pyrene
compounds. Py-pz, on the hand, had featureless broad absorbance. Nanojars containing py-pz had
slightly blue shifted λmax as compared to the ligand.
0.5
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Figure 3.13. UV/Vis absorption spectra of 10 μM solutions of fluorescent ligands and select
nanojars in acetonitrile. The concentrations of nanojars were estimated using the mass of the most
abundant species.
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Table 3.1. Absorbance wavelength maxima of fluorescent ligands and select nanojars in
acetonitrile.

λmax (nm)
Py-pz

352

Pz-alk-py

361

Pz-tri-py

342

Py-pz NJ

349

[1:1] [pz:py-pz] NJ

349

3.6.2. Fluorescence spectroscopy
Fluorescence spectra of ligands and select nanojars in acetonitrile are shown in Figure 3.14.
All measurements were carried out with an excitation wavelength (λEx) of 350 nm. Interestingly,
py-pz had a significantly higher emission intensity than the other two ligands. As expected, the
fluorescence intensity of the nanojars were considerably diminished. We presume that intersystem
crossing induced by paramagnetic copper is the cause for this. The relative quantum yields (ΦEm)
of py-pz and its nanojar mixture was determined using 9,10-diphenylanthracene as the standard.
Py-pz had an ΦEm of 0.26 whereas the nanojar had a ΦEm of 0.046.
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Figure 3.14. Fluorescence spectra 10 μM solutions of fluorescent ligands and select nanojars in
acetonitrile (λEx = 350 nm). The concentrations of nanojars were estimated using the mass of the
most abundant species. NJ = nanojar.
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CHAPTER IV

IMPURITY AMPLIFICATION IN NANOJARS

4.1. Initial discovery
Nanojar synthesis with 4-(4-pentylnyl)pyrazole containing 2.5% allyl pyrazole impurity
(Section 3.1.1) afforded an unexpected distribution of peaks in the mass spectrum (Figure 4.1).
The parent peak for each size of nanojar was accompanied by a set of equally spaced peaks in
decreasing mass and abundance. Careful inspection revealed that this difference can be attributed
to replacing one of the original alkyne ligands with one of the alkene impurity. Since allyl pyrazole
is lower in mass than the alkyne ligand, each substitution results in a smaller m/z for the nanojar,
appearing on the left of the parent nanojar in the mass spectrum. Each peak arises from one
additional ligand replacement than the neighboring peak to the right.
Evaluating the purity of synthetically prepared novel compounds is an essential part of its
characterization prior to publication. This is particularly critical when investigating biological
activity of organic compounds as small amounts of impurities can have drastically different effects
from the primary component.68 Peer reviewed journals often cite a minimum purity requirement
of 95% for publication.69,70 However, when it comes to synthesizing large, self-assembled
structures, there has not been emphasis on the necessity for ultrapure building blocks. We
demonstrate here that small amounts of ligand impurities will be amplified in nanojars.
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Figure 4.1. ESI-MS of nanojar mixture using 4-(4-pentylnyl)pyrazole containing 2% of allyl
pyrazole impurity. Numbers in square brackets indicate the ratio between the pyrazolyl ligands in
each species.
4.2. Distributions of nanojars with pyrazole and 4-methylpyrazole
To further investigate this phenomenon, nanojars were synthesized with a binary system
of ligands with varying mole ratios. Pyrazole (pz) and 4-methylpyrazole (Mepz) were chosen for
their relatively similar electronic and steric properties, and high ionization efficiencies of their
respective nanojars in ESI-MS. Nanojars with [pz:Mepz] ratios ranging from [100:0] to [90:10]
gave distributions with ESI-MS similar to those observed previously (Figure 3.4). The
distributions of each nanojar size was qualitatively similar indicating that there is no preference
between pyrazole and 4-methylpyrazole to forming different sized nanojars. Nanojars containing
one 4-methylpyrazole substituent is evident even at 1%. At 3%, the parent nanojar peak heights
have been reduced approximately by half, and after 4% they are no longer the dominant species.
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The parent peaks are significantly diminished at 10% showing at least six distinct assemblies
containing 4-methylpyrazole substituents for each nanojar size.

Figure 4.2. Nanojar synthesis with varying ratios of pyrazole (pz) and 4-methylpyrazole (Mepz)
as ligands with pyrazole as major component. Values above peaks represent number of 4methylpyrazole substitutions from the pure pyrazole nanojar in each corresponding peak.
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4.3. Theoretical interpretation
Weak interactions that govern self-assembly allows the interconversion of different species
to find the most energetically favored structures. Thus, self-assembly is often a thermodynamically
driven process.71 In the case of nanojars, the lability of Cu-N coordination bonds allows conversion
of tri-, tetra and hexa-nuclear copper(II) pyrazolate species to the more stable nanojars.59 The
formation of different sized nanojars may indicate that their relative thermodynamic stabilities are
similar. On the other hand, the mechanisms that govern the formation heteroleptic nanojars have
not been explored thus far. Here we describe elementary statistical models to study distributions
of nanojars observed with different combinations of pyrazole ligands.
A general representation for the synthesis of nanojars with a binary set of ligands is given
by equation (1):
𝑓{𝑋} + 𝑔{𝑌} → 𝛾(1){𝑋𝑛 } + 𝛾(2){𝑋𝑛−1 𝑌} + ⋯ + 𝛾(𝑛 − 1){𝑋𝑌𝑛−1 } + 𝛾(𝑛){𝑌𝑛 }

(1)

X and Y are the two different ligands and each term on the right is a possible combination of these
to form a nanojar of size n. Terms f and g represent the mole fractions of X and Y, respectively.
Coefficients γ(n) are the relative fractions of each respective species. This equation is reminiscent
of the binomial distribution. The binomial distribution has been used previously to describe the
spread of ligands on the surface of gold nanoparticles.72,73 We have adapted these established
models to analyze the distributions of nanojars. In general terms, the binomial distribution gives
the probability Pth of a certain event occurring m number of times in n trials when the expectation
of it happening for any given trial is p. The general form for the distribution is given by the
𝑛
following equation, in which (𝑚
) is the binomial coefficient:
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𝑛
𝑃th = ( ) 𝑝𝑚 (1 − 𝑝)𝑛−𝑚
𝑚

(2)

𝑛
𝑛!
( )=
𝑚
𝑚! (𝑛 − 𝑚)!

(3)

𝑃th =

𝑛!
𝑝𝑚 (1 − 𝑝)𝑛−𝑚
𝑚! (𝑛 − 𝑚)!

(4)

If we consider X as the major component in equation (1), we can contextualize p as the
probability of finding a Y instead of an X on any given position on a nanojar. Thus, the number of
trials n would be the size of the nanojar considered and m would be the number of Y substituents.
The probability of finding a Y over X will depend on the total relative amounts of each and will be
equal to the mole fraction of Y in the bulk material (i.e., p = f).
Applying the binomial distribution to equation (1), we see that the coefficients of the terms
on the right-hand side provide the probability of getting the corresponding combination of ligands
according to the equation:
𝑛
𝛾(𝑛) = ( ) 𝑓 𝑚 (1 − 𝑓)𝑛−𝑚
𝑚

(5)

where f is the mole fraction of Y in the bulk mixture.
The Poisson distribution can be used as an approximation of the binomial distribution when
𝑛 → ∞ and 𝑝 → 0. The general form is given by:

𝑃th = 𝑒

−𝑛𝑝

(𝑛𝑝)𝑚
𝑚!

Once again, substituting p = f gives us the following:
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(6)

𝑃th = 𝑒 −𝑛𝑓

(𝑛𝑓)𝑚
𝑚!

(7)

The peak intensities in the mass spectrum were normalized by dividing each peak by the
sum of intensities of all the identified peaks within a given size of nanojar:
𝑃ex =

𝐼𝑛,𝑚
𝑛
∑𝑚=0 𝐼𝑛,𝑚

(8)

where In,m is the peak intensity for nanojar of size n with m ligand substitutions. It must be noted
that the intensity of the highest signal for a given species was used in this study, and therefore,
does not account for the isotopic distribution within the signal. Binomial and Poisson distributions
were derived using “BINOM.DIST” and “POISSON.DIST” functions in Microsoft Excel. Plots
comparing theoretical and experimental data for the reaction of [pz:Mepz] = [90:10] are shown in
Figure 4.3 for different sized nanojars. Degree of deviation between theoretical and experimental
values were analyzed using the residual sum of squares (RSS) method.73
The binomial and Poisson models do not differ significantly for the sizes of nanojars in
consideration. A qualitative analysis shows that the distributions observed experimentally can be
adequately simulated using these two models, suggesting that the incorporation of ligands during
nanojar formation with pyrazole and 4-methylpyrazole as ligand mixture is largely random. This
also indicates that the thermodynamics and kinetics of formation of nanojars containing different
ratios of pyrazole and 4-methylpyrazole are not significantly different. Several criteria must be
met for this process to be truly random: 1) the binding affinity of the two ligands must be identical;
2) the substitution of one ligand does not change the probability of substitution of the others on a
nanojar; 3) each site on the nanojar has equal probability of substitution. In terms of experimental
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measurements, the ionization efficiencies of the different species in ESI-MS must not differ in
order for their distribution to be accurately determined.
The experimental values deviate minutely from the Binomial and Poisson
distributions indicated by their corresponding RSS values (Table 4.1). On average, smaller ligand
substitutions (m ≤ 2) are overestimated and larger substitutions (m > 2) are underestimated. The
distributions for a given nanojar size between different ligand ratios follow a similar pattern. Figure
4.4 shows the comparison between theoretical and experimental distributions for different ratios
of ligands obtained for the Cu31 nanojar. While plots show reasonable agreement between theory
and experiment, the above-mentioned deviations are observed here as well (Table 4.2).
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Figure 4.3. Comparison of Binomial and Poisson distribution models with experimental
normalized peak amplitudes for different sized nanojars. Distributions are given for [90:10]
pz:Mepz ligand combination.
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Figure 4.4. Comparison of simulated and experimental distributions of Cu31 nanojar for varying
ratios of ligand.
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Table 4.1. Summary of RSS for Binomial and Poisson distributions for [90:10] pz:Mepz ligand
combination.

Binomial

Poisson

Cu27

6.2 × 10–03

6.7 × 10–03

Cu29

5.1 × 10–03

5.3 × 10–03

Cu30

5.5 × 10–03

4.7 × 10–03

Cu31

4.5 × 10–03

4.7 × 10–03

Table 4.2. Summary of RSS for Binomial and Poisson distributions of Cu31 nanojar for varying
ratios of ligand.

Binomial

Poisson

[97:3]

2.2 × 10–03

6.9 × 10–04

[95:5]

3.1 × 10–03

3.0 × 10–03

[93:7]

7.0 × 10–03

7.1 × 10–03

[90:10]

4.5 × 10–03

4.7 × 10–03

To better fit the Binomial and Poisson distributions to the observed data, the value for p in
equations (4) and (6) can be empirically estimated:

𝑝𝑎𝑑 =

1 ∑𝑛𝑚=0 𝐼𝑛,𝑚 ∗ 𝑚
(
)
∑𝑛𝑚=0 𝐼𝑛,𝑚
𝑛

(9)

where pad is the empirically adjusted probability. This equation treats the experimental data as a
frequency distribution where Inm is the frequency for each number of substitutions m. Thus,
equation (10) is essentially the division of the mean number of substitutions by the number of
trials n. In our case, n is the size of the nanojar. Resulting pad for different pz:Mepz ligand
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combination is summarized in Table 4.3. Select plots of distributions of Cu31 nanojar using
adjusted probability (pad) are shown in Figure 4.5.
Table 4.3. Empirically adjusted probability values for different ratios of ligand combinations.
Average percent differences between pad and expected p = f are given.

Adjusted probability (pad)
[pz:Mepz]

[97:3]

[95:5]

[93:7]

[90:10]

Cu27

0.0333

0.0552

0.0799

0.1078

Cu29

0.0355

0.0542

0.0804

0.1081

Cu30

0.0351

0.0542

0.0814

0.0999

Cu31

0.0322

0.0549

0.0799

0.1072

Ave. % dif.

17.7

13.3

19.3

9.7

All values of pad were consistently higher than the expected p = f. The Binomial and Poisson
distributions using pad showed better fit with observed values (Table 4.4). The difference in binding
affinity of the two ligands may contribute to this observation. The 4-methylpyrazole is conceivably
a better ligand due to the methyl group which inductively donates electron density to the pyrazole.
If this is the case, we would expect nanojars containing higher number of 4-methylpyrazole
substitutions to be thermodynamically more stable. Under the assumption that nanojar formation
is thermodynamically driven, this would mean that the probability for making a certain
combination will increase as the number 4-methylpyrazole substitutions increase.
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Figure 4.5. Comparison of experimental and theoretical distributions of Cu31 nanojar using
adjusted probability (pad).
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Table 4.4. Summary of RSS for Binomial and Poisson distributions of Cu31 nanojar using adjusted
probability (pad).

Binomial

Poisson

[97:3]

6.9 × 10–04

6.6 × 10–04

[95:5]

2.0 × 10–03

1.2 × 10–03

[93:7]

1.5 × 10–03

6.5 × 10–04

[90:10]

7.7 × 10–04

6.0 × 10–04

4.4. Distributions of nanojar with dissimilar ligands
To further investigate the property of impurity amplification, nanojars were synthesized
with 95:5 (f = 0.05) ligand mixture of 4-(bromopropyl)pyrazole (Br(CH2)3pz) and 4(hydroxypropyl)pyrazole (HO(CH2)3pz). The latter is expected to be significantly more polar than
the former, and therefore, is expected to have a different binding affinity on nanojars.

Figure 4.6. Mass spectra of nanojars with 4-(bromopropyl)pyrazole (top) and [95:5] mixture of
[Br(CH2)3pz:HO(CH2)3pz] (bottom) as ligands. Numbers in square brackets above peaks indicate
ratio of ligands in each species.
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The distributions between the different sized nanojars showed varying patterns of
substitution (Figure 4.7). As expected, Cu27 did not correlate well with the simulated distributions,
where more 4-(hydroxypropyl)pyrazole substitutions were observed than theoretically predicted.
This may suggest that its formation is not completely random. Surprisingly, however, distributions
for Cu29 and Cu31 nanojars agreed well with theoretically predicted values. The discrepancies
between distributions of different sized nanojars may be attributed to their relative abilities to
accommodate the different ligands. The bromo-group is perhaps disfavored in comparison to the
hydroxy group in the Cu27 nanojars, which may account for the higher number of substitutions
with 4-(hydroxypropyl)pyrazole observed experimentally.
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Figure 4.7. Comparison of theoretical and experimental distributions of different sized nanojars
with [95:5] [Br(CH2)3pz:HO(CH2)3pz] ligand mixture.
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In a wider context, the phenomenon of impurity amplification should apply broadly to
discrete self-assembled structures. The effect of ligand impurities on the composition of selfassembled structures is dependent on the number of components in the assembly as illustrated by
Figure 4.8. Since the substitution of even one ligand on an assembly results in a completely distinct
species, the larger the number of components, the more susceptible it is to small amounts of ligand
impurities. It is assumed here that the impurity has similar binding properties as the original ligand.
Non-binding impurities will not alter the composition of the assembly. Furthermore, large
differences in binding affinity of the two ligands may results in the self-sorting behavior where
composition of assemblies containing one type of ligand will be preferred over the other.

2-component

6-component

9-component

33-component

Figure 4.8. Translation of ligand impurity to impurities in self-assembled structures.
The quantitative relationship between the number of components in an assembly and
amount of ligand impurity can be derived by rearranging equation (4). Since we are concerned
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about the purity of the parent assembly containing only the primary ligand, we can set m = 0
resulting in the following:
𝑃th = (1 − 𝑝)𝑛

(10)

1

Raising both sides of the equation to the power of 𝑛 and rearranging gives us:
1

𝑝 = 1 − 𝑃th 𝑛

(11)

By setting Pth = 0.5, we can analyze the amount of impurity required to reduce the purity of the
self-assembled structure by half for a given size of assembly:
1

𝑝 = 1 − 0.5𝑛

(12)

The plot of equation (12) is shown in Figure 4.9.
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Figure 4.9. Plot of equation (12) illustrating relationship between impurity and complex size. n
is the number of components in the complex and p is the mole fraction of impurity.
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Assuming complete random association of ligands to form a set of Binomially distributed
species, equation (12) predicts that only 2.2 mol% of a pyrazole impurity is required to reduce the
purity of a Cu31 nanojar by half. We can extrapolate this model to the largest self-assembled
synthetic structure thus far consisting 96 ligands and 48 metal centers, reported by Fujita and
coworkers.31 In this case only 0.72 mol% of a complexing impurity is needed to reduce the purity
of the desired structure by half.
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CHAPTER IV

CONCLUSIONS AND FUTURE WORK

The synthesis and characterization of nine novel organic compounds are reported in this
work. Of these, three are fluorescent pyrazole derivatives. From these ligands, py-pz was the only
one that unequivocally showed the formation of homoleptic nanojars by ESI-MS (Figure 5.1). We
suspect the lack of formation of nanojars with pz-tri-py is due to the triazole functionality that is
an additional coordination site for copper. We assume that this promotes the formation of other
undesired coordination compounds. Thus, triazole containing ligands should be avoided in the
future for nanojar ligand design.

Figure 5.1. Formation of homoleptic nanojars were unequivocally observed for py-pz.
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While there was qualitative evidence for nanojar formation with pz-alk-py, their
corresponding peaks were not observed in ESI-MS. We believe that nanojars formed with this
ligand would be too large and hydrophobic to be ionized by ESI. This hypothesis is supported by
the low ionization efficiency of heteroleptic nanojars with 50:50 mixture of pz-alk-py and
unsubstituted pyrazole. These results bring to light a key challenge in characterizing nanojars that
contain large hydrophobic functional groups.

Figure 5.2. Heteroleptic nanojars were obtained for pz-alk-py and py-pz with 50:50 ligand mixture
with unsubstituted pyrazole. Nanojars for unsubstituted pyrazole and pz-tri-py formed with 95:5
ligand mixture.
While initial UV/Vis and fluorescence spectra of ligands and some nanojars were obtained,
further studies are necessary to gain a full understanding of their photophysical properties. In
particular, probing the mechanism of fluorescence quenching in nanojars is important.
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Nanojars containing alkyne functionality were synthesized towards performing postsynthetic functionalization using click chemistry. We demonstrated the viability of using this type
of chemistry to attach a pyrene fluorophore. In a broader perspective, we envision using such a
process to couple nanojars with entities such as proteins, DNA and even solid surfaces. Taking
into account the interferences observed in nanojar formation with the triazole containing ligand,
other types of alkyne reactions such as Sonogashira coupling and Glaser coupling may be explored.
Finally, we found that even a small amount of ligand impurity forms distributions of
nanojars thereby significantly decreasing the purity of the parent nanojars. Using the binomial and
Poisson distributions, we were able to show that the formation of these distributions was largely
random when the impurity has similar binding properties to the ligand. When the binding
properties were dissimilar, the observed distributions deviated significantly from the theoretical
models. While these statistical models have been previously used to analyze ligand distributions
on nanoparticles, to the best of our knowledge, this is the first time such analyses have been used
to study the random distributions of self-assembled structures within the context of impurity
amplification.
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APPENDIX A
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H and 13C NMR Spectra
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ESI-MS of Nanojars
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ESI-MS of homoleptic nanojars with 4-(4-pentynyl)pyrazole.

ESI-MS of heteroleptic nanojar with [95:5][pz:pz-tri-py].
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ESI-MS of homoleptic nanojars with py-pz.

ESI-MS of heteroleptic nanojars with [1:1][pz:py-pz].
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ESI-MS of heteroleptic nanojars with [1:1][pz:pz-alk-py].

ESI-MS of heteroleptic nanojars with [90:10][pz:4-(4-pentynyl)pyrazole].
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ESI-MS of homoleptic nanojars with 4-(3-bromopropyl)pyrazole.

ESI-MS of nanojars with 4-(4-pentynyl)pyrazole containing ~2.5% of allyl pyrazole impurity.
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ESI-MS of heteroleptic nanojars with [1:1][pz:4-(3-bromopropyl)pyrazole].
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